Felker, G. M., Redfield, M. M., Mentz, R. J., Dunlap, M. E., Lewis, G. D., Smith, A. L., … Bruanwald, E. (2019). Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies. In Journal of Cardiac Failure (Vol. 25, pp. S75–S75). Elsevier BV. https://doi.org/10.1016/j.cardfail.2019.07.213

Felker, G Michael, Margaret M. Redfield, Robert J. Mentz, Mark E. Dunlap, Gregory D. Lewis, Andrew L. Smith, Steven E. McNulty, et al. “Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies.” In Journal of Cardiac Failure, 25:S75–S75. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.213.

Felker GM, Redfield MM, Mentz RJ, Dunlap ME, Lewis GD, Smith AL, et al. Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies. In: Journal of Cardiac Failure. Elsevier BV; 2019. p. S75–S75.

Felker, G. Michael, et al. “Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies.” Journal of Cardiac Failure, vol. 25, no. 8, Elsevier BV, 2019, pp. S75–S75. Crossref, doi:10.1016/j.cardfail.2019.07.213.

Felker GM, Redfield MM, Mentz RJ, Dunlap ME, Lewis GD, Smith AL, McNulty SE, Desvigne-Nickents P, Anstrom KJ, Hernandez AF, Bruanwald E. Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies. Journal of Cardiac Failure. Elsevier BV; 2019. p. S75–S75.